Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study - Poll - MDSpire

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

  • By

  • Ozlem Candan

  • Narmin Naghizada

  • Tekin Tuncel

  • Beyza Melek Palaz

  • Mustafa Alperen Tunc

  • Derya Demirtas

  • Ahmet Mert Yanik

  • Arda Bayar

  • Secil Salim

  • Fatma Temiz

  • Ceren Uzunoglu Guren

  • Fatma Arıkan

  • Meral Ulukoylu Menguc

  • Asu Fergun Yilmaz

  • Isik Atagunduz

  • Zekaver Odabası

  • Tayfur Toptas

  • Ayse Tulin Tuglular

  • May 14, 2026

  • 0 min

Share

Original Source(s)

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

  • by Ozlem Candan, Narmin Naghizada, Tekin Tuncel, Beyza Melek Palaz, Mustafa Alperen Tunc, Derya Demirtas, Ahmet Mert Yanik, Arda Bayar, Secil Salim, Fatma Temiz, Ceren Uzunoglu Guren, Fatma Arıkan, Meral Ulukoylu Menguc, Asu Fergun Yilmaz, Isik Atagunduz, Zekaver Odabası, Tayfur Toptas, Ayse Tulin Tuglular

  • May 14, 2026

Related Content

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

Differential expression of immune activation markers in T cells from patients with multiple myeloma

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series